Denemek ALTIN - Özgür
Policy Covers NCD Concerns
Bio Spectrum
|April 2017
The National Health Policy 2017 covers various aspects like care for major non-communicable diseases (NCDs), geriatric healthcare, mental health, palliative care and rehabilitative care services.
-
The four main types of NCDs are cardiovascular diseases (like heart attacks and stroke), cancer, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes. These four diseases are largely caused by behavioural risk factors like tobacco use, unhealthy diet, physical inactivity and alcohol use. Additional risk factors like obesity, high blood pressure, high levels of cholesterol and blood glucose are tied to lifestyle choices.
Dr Sushil Shah, Founder & Chairman, Metropolis Healthcare Ltd., “The newly announced health policy hits so many right marks. From focusing on preventive healthcare, pre-screening and targeting NCDs to lowering costs of medical services and ensuring access to quality healthcare despite financial barriers.”
“Cancer, diabetes and heart diseases account for 55 per cent of premature mortality of India in the age group of 30-69 years. One in four Indians face the risk of death from an NCD before they hit the age of 70,” states global status report on NCDs by WHO. The report also states, “NCDs contributed to 5.8 million deaths, accounting for 60 per cent of all deaths in India”. Such alarming figures can only be improved by proper monitoring and implementation of the policy.
Appreciating the Healthy Ministry and its emphasis on creating awareness about NCDs, Dr Kenneth E Thorpe, Chairman, PFCD said, “The announcement of the policy is a clear indication of the government’s long-term commitment to find sustainable solutions to address the growing burden of NCDs as well as the recognition of the socio-economic impact of NCDs on the country.”
Bu hikaye Bio Spectrum dergisinin April 2017 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Bio Spectrum'den DAHA FAZLA HİKAYE
Bio Spectrum
Can India's CDMOS Lead the Next Biopharma Wave?
India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).
8 mins
March 2026
Bio Spectrum
Telangana turns catalyst for innovation
Telangana is at a pivotal moment in its journey as a global life sciences hub.
6 mins
March 2026
Bio Spectrum
Is AI the New Weapon in the Fight to End TB?
A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).
2 mins
March 2026
Bio Spectrum
ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India
US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.
1 min
March 2026
Bio Spectrum
Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy
Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.
5 mins
March 2026
Bio Spectrum
"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"
Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.
5 mins
March 2026
Bio Spectrum
Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer
Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.
1 min
March 2026
Bio Spectrum
Haleon ropes in Kedar Lele as President for India Subcontinent
Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.
1 min
March 2026
Bio Spectrum
Centre revises Startup Recognition Framework to strengthen Startup India Action Plan
The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.
1 min
March 2026
Bio Spectrum
"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"
In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.
5 mins
March 2026
Translate
Change font size

